- Support sub-regional and regional mechanisms for the regulatory harmonization of vaccines and promote the adoption of vaccine safety standards.
- Support the formulation of national and institutional research and health technology (vaccines) policies that will permit the development of the knowledge and technologies (vaccines) necessary for taking effective action in public health.
- Determine the disease burden and ensure cost-effective inclusion of vaccines against Haemophilus influenzae type b, MR, or MMR within basic vaccination series.
- Promote research and development of vaccines, in collaboration with public sector laboratories, ensuring that local vaccine production is economically and technically viable and adheres to good manufacturing practices, as well as national and international norms and standards.
- Promote the consortium of public laboratories that produce vaccines and the adoption of good manufacturing practices, and continuing the regional certification process for vaccine producers.
|
